Literature DB >> 3797594

The combined use of neuroleptics and ECT in drug resistant schizophrenic patients.

R O Friedel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3797594

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


× No keyword cloud information.
  5 in total

1.  Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.

Authors:  A Fitton; P Benfield
Journal:  Pharmacoeconomics       Date:  1993-08       Impact factor: 4.981

Review 2.  A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1991-10       Impact factor: 3.996

Review 3.  Interactions between psychotropics, anaesthetics and electroconvulsive therapy: implications for drug choice and patient management.

Authors:  Mohamed Naguib; Robert Koorn
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Treatment-refractory schizophrenia.

Authors:  Asaf Caspi; Michael Davidson; Carol A Tamminga
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

5.  Effectiveness of Electroconvulsive Therapy Augmentation on Clozapine-Resistant Schizophrenia.

Authors:  Hye Sung Kim; Se Hyun Kim; Nam Young Lee; Tak Youn; Jeoung Hyuk Lee; Seunghyun Chung; Yong Sik Kim; In Won Chung
Journal:  Psychiatry Investig       Date:  2016-12-29       Impact factor: 2.505

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.